# Tradewind BioScience

Source: https://onco.cc/companies/tradewind-bioscience/  
OnCo record `tradewind-bioscience` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Tradewind is developing a single antibody for ovarian cancer that both attacks the tumour cells directly and helps the immune system attack them too.

## Summary

Tradewind BioScience is a small San Francisco biotech whose lead candidate is a multi-functional therapeutic antibody for ovarian and other metastatic cancers, designed to bind primary cancer cells directly while enabling natural anti-tumour immunity through the same molecule. The company describes its work as translating insights about metastasis into antibody therapeutics. Programmes are preclinical as far as public sources show; no clinical trial registration or financing details were found in a primary source at the time of checking.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: San Francisco, CA
- Type: biotech
- Website: https://www.tradewindbio.com

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/tradewind-bioscience
- Official website: https://www.tradewindbio.com

## Connected records

- cancers: [Ovarian cancer](https://onco.cc/cancers/ovarian/)
- fronts: [Immunotherapy](https://onco.cc/fronts/immunotherapy/), [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- technologies: [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/tradewind-bioscience.json